Rasko JE - Search Results

1

Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer.

Basser RL, Rasko JE, Clarke K, Cebon J, Green MD, Hussein S, Alt C, Menchaca D, Tomita D, Marty J, Fox RM, Begley CG. Basser RL, et al. Among authors: rasko je. Lancet. 1996 Nov 9;348(9037):1279-81. doi: 10.1016/S0140-6736(96)04471-6. Lancet. 1996. PMID: 8909381 Clinical Trial.

2

The cytokine receptor repertoire specifies autocrine growth factor production in factor-dependent cells.

Rasko JE, Metcalf D, Gough NM, Begley CG. Rasko JE, et al. Exp Hematol. 1995 May;23(5):453-60. Exp Hematol. 1995. PMID: 7720817

3

scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice.

Robb L, Rasko JE, Bath ML, Strasser A, Begley CG. Robb L, et al. Among authors: rasko je. Oncogene. 1995 Jan 5;10(1):205-9. Oncogene. 1995. PMID: 7824274

4

The flt3/flk-2 ligand: receptor distribution and action on murine haemopoietic cell survival and proliferation.

Rasko JE, Metcalf D, Rossner MT, Begley CG, Nicola NA. Rasko JE, et al. Leukemia. 1995 Dec;9(12):2058-66. Leukemia. 1995. PMID: 8609717

5

Murine flt3 ligand protects M1 leukemic cells from LIF-induced differentiation and suppression of self-renewal.

Begley CG, Rasko JE, Curtis D, Takagi K, Metcalf D, Hilton D, Roberts B, Nicola NA, Rossner MT. Begley CG, et al. Among authors: rasko je. Exp Hematol. 1996 Aug;24(10):1247-57. Exp Hematol. 1996. PMID: 8765501

6

Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation.

O'Malley CJ, Rasko JE, Basser RL, McGrath KM, Cebon J, Grigg AP, Hopkins W, Cohen B, O'Byrne J, Green MD, Fox RM, Berndt MC, Begley CG. O'Malley CJ, et al. Among authors: rasko je. Blood. 1996 Nov 1;88(9):3288-98. Blood. 1996. PMID: 8896392 Free article. Clinical Trial.

7

Mpl ligand (MGDF) alone and in combination with stem cell factor (SCF) promotes proliferation and survival of human megakaryocyte, erythroid and granulocyte/macrophage progenitors.

Rasko JE, O'Flaherty E, Begley CG. Rasko JE, et al. Stem Cells. 1997;15(1):33-42. doi: 10.1002/stem.150033. Stem Cells. 1997. PMID: 9007220

8

Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer.

Basser RL, Rasko JE, Clarke K, Cebon J, Green MD, Grigg AP, Zalcberg J, Cohen B, O'Byrne J, Menchaca DM, Fox RM, Begley CG. Basser RL, et al. Among authors: rasko je. Blood. 1997 May 1;89(9):3118-28. Blood. 1997. PMID: 9129014 Free article. Clinical Trial.

9

Establishment of multipotential and antigen presenting cell lines derived from myeloid leukemias in GM-CSF transgenic mice.

Rasko JE, Metcalf D, Alexander B, Strasser A, Begley CG. Rasko JE, et al. Leukemia. 1997 May;11(5):732-42. doi: 10.1038/sj.leu.2400614. Leukemia. 1997. PMID: 9180300

10

Multilineage mobilization of peripheral blood progenitor cells in humans following administration of PEG-rHuMGDF.

Rasko JE, Basser RL, Boyd J, Mansfield R, O'Malley CJ, Hussein S, Berndt MC, Clarke K, O'Byrne J, Sheridan WP, Grigg AP, Begley CG. Rasko JE, et al. Br J Haematol. 1997 Jun;97(4):871-80. doi: 10.1046/j.1365-2141.1997.1212937.x. Br J Haematol. 1997. PMID: 9217191 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

232 results

Search Page

Filters